PuraPharm Corporation Limited

HKEX:1498.HK

0.66 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 22.82947.22182.623107.01456.54885.054100.662126.457116.45493.12474.367104.88483.3986.805156.65209.129232.544232.24322.43846.736
Short Term Investments 28.2622.84928.55815.52935.54136.38539.32141.14528.97331.61229.65929.1726.86626.79122.13814.73821.8099.1689.0465.305
Cash and Short Term Investments 51.08947.22182.623107.01456.54885.054100.662126.457116.45493.12474.367134.054110.256113.596178.788223.867254.353241.41131.48446.736
Net Receivables 63.11112.881113.116156.127209.669300.039277.028263.579220.898262.346241.328290.657266.92242.603295.737231.689154.179161.01894.771103.098
Inventory 146.709175.597203.951190.812210.53199.798173.362190.15214.543210.965236.352259.494277.572300.723240.053167.064127.051107.987105.70789.893
Other Current Assets 35.31513.86945.0232.04335.43625.96628.96827.49277.87631.26767.92248.01936.06535.26340.03535.936.41430.75640.283168.977
Total Current Assets 305.708349.568444.71485.996512.183610.857580.02607.678629.771597.702619.969732.224690.813692.185754.613658.52571.997541.172272.245305.606
Non-Current Assets:
Property, Plant & Equipment, Net 381.569396.905403.904431.077465.648492.063567.292554.436396.312412.909424.581294.676301.026297.059230.201117.383103.51293.71379.577.729
Goodwill 17.94417.94420.99320.99320.99320.99388.33988.33988.33988.339155.685155.685155.685155.685148.39700000
Intangible Assets 32.69134.74456.95658.63360.60362.055130.311131.259121.268122.614190.59636.1936.14335.17530.48226.4724.2768.9399.2837.134
Goodwill and Intangible Assets 50.63552.68877.94979.62681.59683.048218.65219.598209.607210.953346.281191.875191.828190.86178.87926.4724.2768.9399.2837.134
Long Term Investments 3.55725.99925.97124.37425.03725.12225.89725.82625.72325.75219.256470.16810.74311.54813.95111.1913.5222.49910.77910.531
Tax Assets 08.81910.42611.04710.97110.48311.07511.29110.5912.36317.61416.38317.42516.31314.34112.27.9766.8726.6095.047
Other Non-Current Assets 40.2639.984-16.574-15.623-13.673-15.71-41.989-44.252-44.951-37.437-86.691-486.551-17.425-16.313-14.341-12.2-7.976-6.872-6.60914.263
Total Non-Current Assets 476.024494.395501.676530.501569.579595.006780.925766.899597.281624.54721.041486.551503.597499.467423.031155.043141.31105.15199.562114.704
Total Assets 781.732843.963946.3861,016.4971,081.7621,205.8631,360.9451,374.5771,227.0521,222.2421,341.011,333.1031,296.2621,293.9771,256.941860.248752.752697.332414.171420.31
Liabilities & Equity:
Current Liabilities:
Account Payables 141.6146.379144.095137.911150.649140.679147.167159.344178.2178.985143.5139.201113.153112.19571.65574.19132.73738.09137.15444.546
Short Term Debt 271.768321.995391.493428.645346.685420.91322.099310.731303.183355.312394.055384.028424.562493.744417.719261.048237.363125.431199.963182.692
Tax Payables 5.0182.0663.2491.4397.3213.5784.0362.8455.2825.854.4123.7126.4855.053.2897.2271.0084.6682.5183.78
Deferred Revenue 5.0182.4843.2496.4147.32110.1834.0362.8455.28214.0414.412-384.028-424.562-493.744-417.719-261.048-237.363-125.431-199.9630
Other Current Liabilities -54.782-48.214-35.854-46.914-63.394-50.715-50.944-43.222-84.06-94.093-52.225318.611389.63454.654440.39247.151239.039145.102207.5597.011
Total Current Liabilities 510.222571.089650.327665.406599.231665.314573.561591.887586.087639.08637.654600.725622.421684.094586.989402.76305.521225.952284.385282.575
Non-Current Liabilities:
Long Term Debt 105.93181.09344.37248.6882.08891.997172.137178.992113.842143.715129.391148.123103.51354.277119.76400000
Deferred Revenue Non-Current 17.7131.0760.7621.0250.9611.1742.4033.8531.3512.0380.9573.1945.15151.4841.9031.3991.0271.49701.909
Deferred Tax Liabilities Non-Current 1.5141.7431.8033.0173.3512.6113.4293.2351.8032.6072.2822.5162.1282.7932.6941.5840.0290.1730.0540.013
Other Non-Current Liabilities 15.88134.6532.02639.05541.15542.03580.01781.09955.20270.64153.718-5.71-7.279-54.277-4.5970001.7860
Total Non-Current Liabilities 141.039118.56278.96391.777127.555137.817257.986267.179172.198219.001186.348148.123103.51354.277119.7642.9831.0561.671.841.922
Total Liabilities 651.261689.651729.29757.183726.786803.131831.547859.066758.285858.081824.002770.884733.213744.895711.35405.743306.577227.622286.225284.497
Equity:
Preferred Stock 424.696000000000020.96612.67813.69224.43232.71817.1715.28700
Common Stock 306.82306.82306.82306.82306.82306.042306.042306.042306.042204.028191.981191.981191.981191.981191.981174.375174.375174.3753030
Retained Earnings -377.376-386.511-318.124-280.449-202.062-160.538-26.531-38.505-58.26-69.697112.381184.393176.935164.121171.37162.232118.419130.0794.01681.68
Accumulated Other Comprehensive Income/Loss -20.54414.2158.92613.20630.54538.08629.51629.7215.23410.50812.035-20.966-12.678-13.692-24.432-32.718-17.171-5.2873.93-60.017
Other Total Stockholders Equity -203.125218.712218.712218.712218.712217.968217.968214.4214.4217.284199.654185.845194.133192.98182.24117.898153.381165.265084.026
Total Shareholders Equity 130.471153.236216.334258.289354.015401.558526.995511.658467.416362.123516.051562.219563.049549.082545.591454.505446.175469.71127.946135.689
Total Equity 130.471153.236216.334258.289354.015401.558526.995511.658467.416362.123516.051562.219563.049549.082545.591454.505446.175469.71127.946135.813
Total Liabilities & Shareholders Equity 781.732843.963946.3861,016.4971,081.7621,205.8631,360.9451,374.5771,227.0521,222.2421,341.011,333.1031,296.2621,293.9771,256.941860.248752.752697.332414.171420.31